+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cough Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon

    Report

  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5464087
Cough pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Cough pipeline drugs and companies” presents key-decision makers with critical insights into Cough pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Cough pipeline Drug Snapshot, 2021


The Cough pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Cough. In addition to recent status, overview of drugs is included in the study. Wide range of Cough drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Cough drug development pipeline by phase


The Cough pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Cough pipeline candidates is provided in the report enables you to understand timetable developments in Cough therapeutic area.

Cough pipeline drug Technology, Licensing and Collaboration Details


Details of technologies used for development of Cough pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Cough research study. Companies looking to partner with other players are also detailed in the report.

Cough- mechanism of action of pipeline candidates


Cough pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Cough companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Cough drug administration.

Cough Drugs- Preclinical and Clinical Trials


This chapter in Cough preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Cough product area. Preclinical and clinical trial details of pipeline candidates for Cough are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Cough companies and Profiles


Companies developing Cough pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Cough Market Developments


The report presents the recent news and developments in the Cough pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Cough R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Cough pipeline drugs and clinical trials
  • Identify Cough drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Cough drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Cough pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Cough pipeline news, developments and insights

Scope of the Report

  • Disease overview including Cough symptoms, widely used treatment options, companies and other details are included
  • Cough Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Cough pipeline drug count by phase, company and mechanism of action
  • Cough companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Cough pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Cough companies including their business snapshot, business description and Cough pipelines are included.
  • Recent Cough market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Cough Disease overview
2.2 Companies investing in Cough industry
3 Cough Pipeline Snapshot, 2021
3.1 Cough Pipeline Drugs- Dominant phase type
3.2 Cough pipeline Drugs- Leading Mechanism of Action
3.3 Cough Pipeline Drugs- Widely researched Route of Administration
3.4 Cough Pipeline- New Molecular Entity
3.5 Cough pipeline- Companies, Universities and Institutes
4. Cough Drug Profiles
4.1 Current Status of Cough Drug Candidates, 2021
4.2 Cough Drugs in Development- Originator/Licensor
4.3 Cough Drugs in Development- Route of Administration
4.4 Cough Drugs in Development- New Molecular Entity (NME)
5. Cough Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Cough Companies and Universities
6.1 Leading Cough companies researching in drug development
6.2 Leading Cough Universities/Institutes investing in drug development
7. Cough News and Deals
7.1 Recent Cough Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact